Manufacturers Life Insurance Company, The Agios Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 122,094 shares of AGIO stock, worth $4.33 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
122,094
Previous 143,431
14.88%
Holding current value
$4.33 Million
Previous $6.37 Million
37.04%
% of portfolio
0.0%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding AGIO
# of Institutions
244Shares Held
59.9MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$201 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$200 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$172 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$125 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$86 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.94B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...